IPO registrations (S-1, F-1) · Registrants
Seer, Inc.
- SEC CIK
- 1726445 · filings on EDGAR ↗
- Former names
- Seer Biosciences, Inc. (2018–2018)
- Registration
- Form S-1, first filed 2020-11-12, last 2021-01-25; 2 initial registrations, 1 amendment
- Outcome
- Final prospectus filed 2020-12-04; declared effective 2020-12-03
- Industry (SIC)
- Laboratory Analytical Instruments 3826
- Incorporated in
- DE
- Business address
- 3800 BRIDGE PARKWAY, SUITE 102, Redwood City, CA 94065
- EIN
- 82-1153150
- Ticker
- SEER (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Seer, Inc. on the corporate pages
Offering terms
- Proposed price range
- $16.00–$18.00 per share (S-1/A filed 2020-11-30)
- Final price
- $19.00 per share, above the range (424B4 filed 2020-12-04, an initial public offering)
- Shares sold
- 9,210,527
- Gross proceeds
- $175,000,013 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol SEER
- Lead underwriters
- J.P. Morgan (3,131,580 shares); Morgan Stanley (3,131,579 shares); BofA Securities (1,842,105 shares); Cowen (1,105,263 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: SEER, INC. EXACT (EIN (EXACT))
- Federal award recipient: SEER, INC. Fuzzy (name and state)
- Form D issuer: Seer Biosciences, Inc. EXACT (CIK (EXACT))
- SEC filer: Seer, Inc. EXACT (CIK (EXACT))
Filings 9
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2020-11-12 | S-1 | S-1 (registration) | Seer, Inc. | 0001628280-20-016325 ↗ |
| 2020-11-30 | S-1/A | S-1/A (amendment) | Seer, Inc. | 0001628280-20-016863 ↗ |
| 2020-12-03 | S-1MEF | S-1MEF (added securities) | Seer, Inc. | 0001628280-20-017076 ↗ |
| 2020-12-03 | EFFECT | EFFECT (declared effective) | Seer, Inc. | 9999999995-20-003392 ↗ |
| 2020-12-04 | 424B4 | 424B4 (final prospectus) | Seer, Inc. | 0001628280-20-017127 ↗ |
| 2021-01-25 | S-1 | S-1 (registration) | Seer, Inc. | 0001628280-21-000787 ↗ |
| 2021-01-27 | S-1MEF | S-1MEF (added securities) | Seer, Inc. | 0001628280-21-000922 ↗ |
| 2021-01-27 | EFFECT | EFFECT (declared effective) | Seer, Inc. | 9999999995-21-000315 ↗ |
| 2021-01-29 | 424B4 | 424B4 (final prospectus) | Seer, Inc. | 0001628280-21-001070 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-11-30 | S-1/A | registration statement | $16.00–$18.00 | 8,825,000 | - | Nasdaq SEER | 4 | primary document; range, shares headline, cover names 4 | document ↗ | |
| 2020-12-04 | 424B4 | final prospectus | $19.00 | 9,210,527 | $175,000,013 | Nasdaq SEER | 4 | primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| AINSLIE LEE S III | Director; TenPercentOwner | 4 | 2020–2021 | ||
| aMoon 2 Fund Limited Partnership | TenPercentOwner | 3 | 2020–2021 | ||
| Artal Group S.A. | TenPercentOwner | 3 | 2020–2021 | ||
| Artal International Management S.A. | TenPercentOwner | 3 | 2020–2021 | ||
| Artal International S.C.A. | TenPercentOwner | 3 | 2020–2021 | ||
| Artal Treasury Ltd | TenPercentOwner | 3 | 2020–2021 | ||
| Farokhzad Omid | Director,Officer; Director,Officer,TenPercentOwner | CEO and Chair; CEO AND CHAIR; CEO and Chair of the Board; CEO, President and Chair | 29 | 2020–2026 | |
| FRIEDMAN CATHY | Director | 5 | 2020–2023 | ||
| Hallal David | Director | 6 | 2020–2024 | ||
| Horn David R. | Officer | Chief Financial Officer; President and CFO; President & CFO; PRESIDENT & CFO | 30 | 2020–2026 | |
| Invus Public Equities Advisors, LLC | TenPercentOwner | 3 | 2020–2021 | ||
| Invus Public Equities, L.P. | TenPercentOwner | 3 | 2020–2021 | ||
| Kogan Elona | Officer | Chief Legal Officer; CHIEF LEGAL OFFICER; General Counsel and Secretary | 8 | 2020–2024 | |
| LANGER ROBERT | Director | 10 | 2020–2026 | ||
| Maverick Advisors Fund, L.P. | Director; TenPercentOwner | 4 | 2020–2021 | ||
| Maverick Capital Ventures, LLC | Director; TenPercentOwner | 4 | 2020–2021 | ||
| Maverick Ventures Investment Fund, L.P. | Director; TenPercentOwner | 4 | 2020–2021 | ||
| MCGUIRE TERRANCE | Director | 10 | 2020–2026 | ||
| Minne Pascal | TenPercentOwner | 2 | 2020 | ||
| OSTADAN OMEAD | Director,Officer | President & COO | 10 | 2020–2022 | |
| Schindel Yair Chaim | Other; TenPercentOwner | 3 | 2020–2021 | ||
| SINGER DAVID B | Director; Director,TenPercentOwner | 4 | 2020–2021 | ||
| Stichting Administratiekantoor Westend | TenPercentOwner | 3 | 2020–2021 | ||
| Westend S.A. | TenPercentOwner | 3 | 2020–2021 | ||
| Wittouck Amaury | TenPercentOwner | 2 | 2021 | ||
| Ronaghi Mostafa | Director | 4 | 2021–2023 | ||
| Nishar Dipchand | Director | 10 | 2021–2026 | ||
| Haurwitz Rachel E. | Director | 5 | 2021–2024 | ||
| Gulyani Meeta | Director | 7 | 2021–2026 | ||
| Thomas Scott D | Officer | Chief Commercial Officer | 4 | 2022–2023 | |
| Roelofs Nicolas H PHD | Director | 4 | 2024–2026 | ||
| Ro Isaac | Director | 3 | 2025–2026 | ||
| Bazarko Anthony R. | Officer | Chief Commercial Officer | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2018-01-04 | Seer Biosciences, Inc. | Biotechnology | $6,000,000 | $6,000,000 | 11 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | SEER, INC. | CA | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Form D issuer | Seer Biosciences, Inc. | MA | Form D private offerings | CIK (EXACT) |
| SEC filer | Seer, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | SEER, INC. | EIN (EXACT) | ||
| Federal award recipient | SEER, INC. | Federal spending (USAspending) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Laboratory Analytical Instruments, CA first:
- NGEN, INC. CA
- CEPHEID CA
- LJL BIOSYSTEMS INC CA
- AGILENT TECHNOLOGIES, INC. CA
- ILLUMINA, INC. CA
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CA
- QPC Lasers CA
- WaferGen Bio-systems, Inc. CA
- PROTEINSIMPLE CA
- Bionano Genomics, Inc. CA
In other datasets, the same topic (Technology) in CA:
- Lobbying client: 8X8, INC. (Federal lobbying (LDA))
Interests: Laboratory Analytical Instruments · Technology